Mallinckrodt plc (in examinership) receives u.s. court approval for financial restructuring plan

Dublin , oct. 10, 2023 /prnewswire/ -- mallinckrodt plc (in examinership) (otcmkts: mnktq) ("mallinckrodt" or the "company"), a global specialty pharmaceutical company, today announced that its plan of reorganization (the "plan") has been confirmed by the u.s. bankruptcy court for the district of delaware, positioning the company to emerge from chapter 11 by the end of the year. siggi olafsson, president and chief executive officer of mallinckrodt, said, "we are pleased to achieve this important milestone and look forward to moving ahead as a stronger company.
MNK Ratings Summary
MNK Quant Ranking